Literature DB >> 8627293

Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway.

D A Wiesner1, G Dawson.   

Abstract

We activated the death pathway in embryonic chick cerebral hemisphere neuron (E7CH) cultures with staurosporine (0.1-1.0 microM) and observed the meporphological changes, DNA laddering patterns, and DNA fragmentation (determined by Hoechst 33258 dye) associated with apoptosis. N-Acylsphingosine (C2-ceramide), a soluble ceramide analogue, was also able to induce apoptosis in these cells with the same characteristics and in the same time frame. We then observed that staurosporine was effective in inducing hydrolysis of sphingomyelin to ceramide as measured by a threefold increase in ceramide mass and increased incorporation of [3H]-palmitate into ceramide, concurrent with activating the cell death program. Furthermore, the coaddition of a specific ceramidase inhibitor, oleoylethanolamine (15 microM), enhanced the formation of ceramide as well as the degree of DNA fragmentation and cell death. Exogenous addition of sphingomyelinase activated the death pathway whereas ceramide glycanase did not, and inhibitors of sphingomyelin or protein synthesis failed to block this type of killing. Our data suggest that formation of ceramide from sphingomyelin is a key event in staurosporine-induced and potentially all programmed cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627293     DOI: 10.1046/j.1471-4159.1996.66041418.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

2.  Simultaneous labeling of projecting neurons and apoptotic state.

Authors:  Steve M Nguyen; Christopher J Lieven; Leonard A Levin
Journal:  J Neurosci Methods       Date:  2006-12-20       Impact factor: 2.390

Review 3.  Measuring brain lipids.

Authors:  Glyn Dawson
Journal:  Biochim Biophys Acta       Date:  2015-02-18

4.  Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration.

Authors:  C Harms; M Lautenschlager; A Bergk; J Katchanov; D Freyer; K Kapinya; U Herwig; D Megow; U Dirnagl; J R Weber; H Hörtnagl
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.

Authors:  J Tohyama; Y Oya; T Ezoe; M T Vanier; H Nakayasu; N Fujita; K Suzuki
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 6.  Sphingolipids and mitochondrial apoptosis.

Authors:  Gauri A Patwardhan; Levi J Beverly; Leah J Siskind
Journal:  J Bioenerg Biomembr       Date:  2016-04       Impact factor: 2.945

7.  Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.

Authors:  Jingdong Qin; Evgeny Berdyshev; Jonathan Goya; Viswanathan Natarajan; Glyn Dawson
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

Review 8.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Authors:  Judith A Hobert; Glyn Dawson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-19       Impact factor: 3.575

10.  Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.